Preliminary results of a phase I study of sunitinib plus paclitaxel for first-line treatment of advanced breast cancer

被引：0
|
作者：
Kozloff, Mark [1 ]
Chuang, Ellen [2 ]
Roy, Jessica [3 ]
Starr, Alexander [1 ]
Gowland, Patricia A. [1 ]
Tarpey, Matthew J. [2 ]
Collier, Mary [4 ]
Verkh, Lev [4 ]
Kern, Kenneth [4 ]
Miller, Kathy [3 ]
机构：
[1] Ingalls Mem Hosp, Harvey, IL USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] Indiana Univ Canc Ctr, Indianapolis, IN USA
[4] Pfizer Global Res & Dev, La Jolla, CA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3591S / 3591S
页数：1
相关论文
共 50 条
  • [31] Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer
    Cardoso, F.
    Canon, J. L.
    Amadori, D.
    Dirix, L.
    Villa, E.
    Aldrighetti, D.
    Machiels, J. P.
    Verkh, L.
    Kern, K.
    Giorgetti, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 283 - 283
  • [32] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [33] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Heath, Elisabeth I.
    Blumenschein, George R., Jr.
    Cohen, Roger B.
    LoRusso, Patricia M.
    LoConte, Noelle K.
    Kim, Sindy T.
    Ruiz-Garcia, Ana
    Chao, Richard C.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 703 - 712
  • [34] Letrozole (LE)-Vinorelbine (VIN) as first-line treatment in advanced breast cancer (ABC) patients: Preliminary results of a multicentre Phase II study
    Barni, S.
    Colina, P.
    Leo, S.
    Sandri, P.
    Savarino, A.
    Pollera, F.
    Ardizzoia, A.
    Barberis, G.
    Mari, Di
    Cazzaniga, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 129 - 129
  • [35] Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer:: a phase II study
    Feliu, J
    Salud, A
    Escudero, P
    Lòpez-Gómez, L
    Pericay, C
    Castañón, C
    de Tejada, MRL
    Rodríguez-García, JM
    Martínez, MP
    Martín, MS
    Sánchez, JJ
    Barón, MG
    BRITISH JOURNAL OF CANCER, 2004, 90 (08) : 1502 - 1507
  • [36] Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study
    J Feliu
    A Salud
    P Escudero
    L López-Gómez
    C Pericay
    C Castañón
    M R López de Tejada
    J M Rodríguez-García
    M P Martínez
    M Sanz Martín
    J J Sánchez
    M González Barón
    British Journal of Cancer, 2004, 90 : 1502 - 1507
  • [37] Paclitaxel plus ifosfamide in advanced ovarian cancer: results of a phase I study
    Klaassen, U
    Harstrick, A
    Strumberg, D
    Wilke, H
    Seeber, S
    ANTI-CANCER DRUGS, 1998, 9 (04) : 359 - 361
  • [38] Results of a phase II study of pemetrexed as first-line chemotherapy for advanced or metastatic breast cancer
    Robert, N. J.
    Conkling, P. R.
    Kuefler, P. R.
    McIntyre, K. J.
    Zhan, F.
    Asmar, L.
    Wang, Y.
    Shonukan, O. O.
    O'Shaughnessy, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Sunitinib in combination with folfiri as first-line treatment for metastatic CRC: A phase I study
    Carrato, A.
    Starting, N.
    Vazquez, F.
    Hill, P.
    Lechuga, M.
    Brega, N.
    Chao, R.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2007, 18 : VII29 - VII29
  • [40] Cetuximab plus docetaxel-cisplatin (DC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase II study
    Fahlke, J.
    Ridwelski, K.
    Florschuetz, A.
    Kettner, E.
    Leithaeuser, M.
    Kroehning, H.
    Stuebs, P.
    Zierau, K.
    Lippert, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345